Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2010; 16(37): 4716-4724
Published online Oct 7, 2010. doi: 10.3748/wjg.v16.i37.4716
Published online Oct 7, 2010. doi: 10.3748/wjg.v16.i37.4716
Table 5 Statistical analysis of p16 expression and clinicopathologic factors
| p16 (-) | p16 (+) | P value (χ2) | |
| Sex | |||
| Male | 12 | 18 | |
| Female | 9 | 12 | 0.838 (0.042) |
| Age (yr) | |||
| < 50 | 5 | 4 | |
| ≥ 50 | 16 | 26 | 0.334 (0.933) |
| Size (cm) | |||
| < 5 | 4 | 13 | |
| ≥ 5 | 17 | 17 | 0.070 (3.279) |
| Mitotic index | |||
| ≤ 5/50 HPF | 8 | 21 | |
| > 5/50 HPF | 13 | 9 | 0.024 (5.126) |
| Risk | |||
| Very low and low | 4 | 13 | |
| High | 12 | 8 | 0.045 (4.98) |
| Site | |||
| Stomach | 13 | 17 | |
| Intestine | 7 | 11 | |
| Other | 1 | 2 | 0.917 (0.173) |
- Citation: Zhang Y, Cao H, Wang M, Zhao WY, Shen ZY, Shen DP, Ni XZ, Wu ZY, Shen YY, Song YY. Loss of chromosome 9p21 and decreased p16 expression correlate with malignant gastrointestinal stromal tumor. World J Gastroenterol 2010; 16(37): 4716-4724
- URL: https://www.wjgnet.com/1007-9327/full/v16/i37/4716.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i37.4716